Assessment of Dietary Acid Load in Children with Chronic Kidney Disease: An Observational Study
Project Description
Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation. Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation.Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation.
Project Duration
2024 - 2025
Project Lead
Arpana Iyengar
Authors
Sravani M, Collins S, Iyengar A.
Project Status
completed
Project Type
International Society of Nephrology’s educational grants